Next Article in Journal
Enterotoxin- and Antibiotic-Resistance-Encoding Genes Are Present in Both Coagulase-Positive and Coagulase-Negative Foodborne Staphylococcus Strains
Previous Article in Journal
A Comparison of Three Culture Media for the Detection of Rapid-Growing Nontuberculous Mycobacteria in Environmental Samples
Previous Article in Special Issue
Effect of Enterocins A and B on the Viability and Virulence Gene Expression of Listeria monocytogenes in Sliced Dry-Cured Ham
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Properties against Human Pathogens of Medicinal Plants from New Zealand

1
Chemical and Materials Engineering Department, Faculty of Engineering, Waipapa Taumata Rau University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
2
Seaweed Research Unit, Faculty of Science and Natural Resources, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, Malaysia
3
Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, Waipapa Taumata Rau University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
4
LEAF, Associate Laboratory Terra, Instituto Superior de Agronomia (ISA), Universidade de Lisboa, Tapada da Ajuda, 1349-017 Lisboa, Portugal
*
Authors to whom correspondence should be addressed.
Appl. Microbiol. 2022, 2(2), 357-366; https://doi.org/10.3390/applmicrobiol2020027
Submission received: 17 May 2022 / Revised: 25 May 2022 / Accepted: 30 May 2022 / Published: 31 May 2022

Abstract

:
The emergence of resistant microorganisms towards standard antibiotics has stimulated an on-going exploration for new sources of antimicrobials. The microbial susceptibility of extracts produced from leaf, bark, or rhizome parts of nine different New Zealand bushes was investigated using liquid broth dilution and agar plating techniques. Minimum inhibitory (MIC) and lethal concentrations (MLC) were expressed in micrograms of dry extract per milliliters of solution. The lowest MIC of 62.5 μg/mL was determined for methanol extract of Kunzea ericoides against Bacillus cereus and Candida albicans, and ethyl acetate extract of Pseudowintera colorata against Staphylococcus aureus. Additionally, K. ericoides also presented the lowest MLC of 250 μg/mL against S. aureus and B. cereus (methanol extract), and against S. aureus (ethyl acetate extract). The methanol extract of Weinmannia racemosa was lethal to B. cereus (MLC = 250 µg/mL). Some of the extracts of Phormium tenax, Schefflera digitata, and Pomaderris kumeraho were antimicrobial against S. aureus and B. cereus (MIC = 500 µg/mL). The extracts of Geniostoma ligustrifolium and Melicytus ramiflorus plants did not exhibit antimicrobial activity.

1. Introduction

Hospital-acquired infections and the increasing number of drug-resistant pathogens are major problems in hospitals [1,2]. Over the past few years, health agencies have been trying to minimize the use of antibiotics through various advertising campaigns and to sensitize people towards public health awareness. Despite the development of antibiotics, bacterial and fungal infections are still a public health concern, and the continued emergence of numerous drug-resistant pathogen strains poses a challenge. Some microorganisms are particularly problematical, and this has led the WHO to publish a list of 12 priority organisms for which new antibiotics are urgently needed in 2017 [3]. Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) are a major concern in hospitals as they become resistant to the frequently used antibiotics. In another study, it has been reported that strains such as Staphylococcus aureus SA1199 B (NorA) and XU212 (TetK, PBP2a) are highly resistant to antibiotics. Overexpression of efflux pumps such as NorA is a common mechanism of resistance found in multi-drug-resistant S. aureus due to the mechanism of efflux [4]. Today, bacterial resistance is recognized as a threat to human health. The problem is especially serious in more susceptible patients during chemotherapy and after organ transplantation because of immunosuppression.
The emergence of multi-drug-resistant (MDR) strains in the hospital or other health care facilities has resulted in the emergence and re-emergence of difficult to treat nosocomial infections in patients [5,6]. This has contributed to higher morbidity and mortality rates, increased health care costs due to treatment failures, and longer hospital stays [6,7]. Multi-drug resistant microorganisms can cause fatal infection in hospitals and nursing homes, where patients with open wounds, invasive devices, and immunodeficiency are at higher risk of infection than healthy people. Therefore, the continuing spread of multi-drug-resistant strains and the increased abuse of antibiotics represent a main challenge in present days [6,8].
As a consequence, researchers explore new approaches such as substances derived from natural products to replace, or to be used in combination with conventional antibiotics, on the basis that these natural substances might have a different mode of action and would have potential to combat the resistant microbial strains [9,10]. Plant materials are an interesting source of natural products with potential antimicrobial properties [11]. There has been an encouraging interest towards more detailed studies of plant resources as natural antibiotic substitutes due to their availability and fewer side effects (e.g., toxicity), as well as better biodegradability as compared with the available antibiotics. Plant extracts are known to be active against a wide variety of microorganisms, including the Gram-negative and Gram-positive bacteria in which Gram-negative bacteria were shown to be generally more resistant than Gram-positive.
In New Zealand, there are a number of endemic plants used locally as medicines, for aromatherapy and indirectly in clinical medicine [12,13,14,15,16,17]. The development of novel molecules isolated from NZ endemic medicinal plants is supported by both mātauranga Māori and by western science [18]. Although New Zealand presents a rich and unique flora of native plants, only a few plants have been investigated for antimicrobial properties [19]. Table 1 shows the scientific, common names, and some of the medicinal properties of New Zealand bushes/small trees selected for this study. A study conducted by Wan et al. (1996) with 231 ethanol/aqueous extracts from New Zealand plants revealed inhibitory activity against HIV-1 protease by K. ericoides, P. tenax, P. kumeraho, P. colorata, S. digitata, and W. racemosa extracts, which may indicate the potential of these species also antimicrobials [20]. In this study, 18 extracts from nine New Zealand shrubs were produced, and the antimicrobial potential against five pathogen strains commonly used for microbial susceptibility testing was investigated.

2. Materials and Methods

2.1. Plant Species

The following species/part of the plant were used in this study: kānuka Kunzea ericoides (leaves), horopito Pseudowintera colorata (leaves), kāmahi Weinmannia racemosa (bark), harakeke Phormium tenax (rhizomes), patē Schefflera digitata (leaves), kūmarahou Pomaderris kumeraho (leaves), koromiko Hebe stricta (leaves), hangehange Geniostoma ligustrifolium (leaves), and māhoe Melicytus ramiflorus (leaves) (Table 1). The plants were chosen based on past publications, local and traditional uses, medicinal properties, availability of the plant, and ease of extraction.
Plant materials harvested during late Spring/Summer were supplied and identified by Fred Allen, an expert with a profound knowledge of New Zealand native plants/trees/bushes, from Kiwi Plants Ltd. (Member of Te Paepae Matua mo Te Rongoa, Nga Ringa Whakahaere o te iwi Māori, and Natural Products New Zealand). The plant samples, purchased as dried flakes at moisture content lower than 5%, were further dried in the dark inside an oven at 30–40 °C for 48 h to remove possible moisture. Then, the dried materials were ground, vacuum-sealed, and stored at room temperature under dark conditions until extraction.

2.2. Preparation of Plant Extracts Using Soxhlet Method

For each plant, ten grams of finely ground sample was extracted with 125 mL of either methanol or ethyl acetate using a Soxhlet extractor (Extraction System B-811, BÜCHI Labortechnik AG, Flawil, Switzerland). The solvents ethyl acetate, with relatively low polarity, and methanol, with high polarity, were chosen to ensure the extraction of all sorts of compounds, depending on their polarity and affinity with each solvent. Based on preliminary work, the optimized period for extraction of 10 g ground sample is 12 cycles (40–60 min). The ideal extraction temperature for each solvent was set according to their boiling points. The solution was filtered and concentrated by using a rotary evaporator (Rotavapor R-215, BÜCHI Labortechnik AG, Flawil, Switzerland). The concentrated extracts were further evaporated to dryness via air-drying at ambient temperature for 24 h. All residues were stored in the dark at −70 °C prior to analysis. In general, the methanol extracts were sticky solids with different colors (brown, reddish, dark green, greenish) and the ethyl acetate extracts were either dry or sticky solids (green, black, brown).

2.3. Preparation of Extracts Suspensions for Antimicrobial Testing

The plant extracts were taken out from the −80 °C freezer and thawed at room temperature. Based on the solubility of the dried extracts produced in DMSO, 0.04 g (for S. digitata, K. ericoides, H. stricta, P. tenax, W. racemosa, G. ligustrifolium) or 0.02 g (for P. colorata, P. kumeraho, M. ramiflorus) of the plant extract was weighed and added into 1 mL of dimethyl sulfoxide (DMSO) in a tube to produce extracts with concentrations of 40,000 and 20,000 µg/mL, respectively. The suspension was mixed well until homogeneity was reached and kept in the −80 °C freezer.

2.4. Microorganisms

Bacterial and fungal species representative of key pathogens and widely accepted as testing strains for antimicrobial activity were chosen. Two pathogenic Gram-positive bacteria, Staphylococcus aureus (ATCC 6538) and Bacillus cereus (ATCC 10702); one pathogenic Gram-negative bacterium, Escherichia coli (ATCC 25922); a pathogenic yeast, Candida albicans (ATCC 10231); and a mould, Aspergillus niger (ATCC 16404) (recently renamed to Aspergillus brasiliensis) were used. The microorganisms were obtained from the New Zealand Reference Culture Collection, Institute of Environmental Science and Research (ESR, Wellington, New Zealand).

2.5. Preparation of Agar and Broth Media, and Microbial Cultures

2.5.1. Preparation of Agar Plates and Broth Growth Media

For the preparation of different types of agar plates, first 7.5 g of granulated agar was added to 500 mL of distilled water. Then, for Tryptic Soy Agar (TSA) 15 g of Tryptic Soy broth powder was added, while for Mueller Hinton (MH) II cation-adjusted agar, 11 g of MH II cation-adjusted broth powder was added. For Yeast Extract−Peptone−Dextrose (YPD), agar 25 g of YPD broth powder was added. Then each solution was sterilized by autoclaving, and plates were filled with the warm solution and left to solidify, then inverted. To prepare YPD broth medium, 25 g of YPD broth was added to 500 mL of distilled water, while for MH II cation-adjusted broth medium 11 g of MH II cation-adjusted broth powder was mixed with 500 mL of distilled water.

2.5.2. Preparation of Microorganism Colonies in Agar Plates

All the microorganisms except A. niger were streaked on TSA agar plates and incubated overnight at 37 °C. The plates with microbial colonies were then stored in a refrigerator at 4 °C for further use throughout the experiments when needed. For Aspergillus niger, the streaking was carried out on a YPD agar plate and kept at 28 °C until a fair amount of spore growth had been achieved (judged based on the intensity of the black color of the spores), which took approximately two weeks.

2.5.3. Preparation of Fresh Overnight Microorganism Cultures in Broth and Inoculum

The following procedure was used for E. coli, S. aureus, B. cereus, and C. albicans. For each species, a small amount of the microorganism colony was streaked out from the agar plate using a sterile plastic loop and mixed into 10 mL of Mueller Hinton II cation-adjusted broth in a falcon tube (50 mL, V-bottom). The cultures were mixed well and incubated overnight in a rotary incubator at 37 °C and 200 rpm. For antimicrobial testing, 2 µL (for E. coli), 20 µL (for S. aureus), 40 µL (for C. albicans), and 12 µL (for B. cereus) were taken out from the respective overnight cultures and each was added into 20 mL of MH II cation-adjusted broth in different falcon tubes to yield approximately a final concentration of the microorganism of 1 × 106 cfu/mL. The inoculum was mixed well in the falcon tubes.

2.5.4. Preparation of A. niger Inoculum

For the preparation of A. niger inoculum, firstly, about 10–15 mL of YPD broth was poured onto the agar plate containing grown colonies. Then, the agar surface was streaked by using an L-shaped stick to harvest the spores. After that, all the harvested spores were poured into the falcon tube. A series of half dilution was performed by adding 1 mL of YPD broth with 1 mL of the harvested spores inside a yellow-capped tube. After a good vortex, 1 mL was taken out from this mixture and added into the second tube labeled ‘2’ containing 1 mL of YPD broth. The steps were continued 4–5 times to reach 4–5 half dilutions. The correct dilution for the assay was chosen by counting the spores using a hemocytometer.

2.6. Determination of MIC and MLC of Plants Extracts

The antimicrobial activity of each extract was quantified by determining the minimum inhibitory concentration (MIC) using the liquid broth micro-dilution and minimum lethal concentration (MLC) using the agar plating technique from the NCCLS standards [22]. For bacteria and Candida albicans, MH broth and agar were used, while for the mould A. niger, YPD was selected as it provides a consistent result with this particular mould.

2.6.1. Determination of MIC

The plant extract suspension was thawed at room temperature and vortexed. A microplate was prepared for each microorganism (S. aureus, B. cereus, E. coli, C. albicans) as follows: 10 µL of plant extract suspension and 90 µL of MH II cation-adjusted broth were added into 3 wells of the first row (3 replicates). Then a blank sample containing only DMSO (no plant extract) was also tested for any antimicrobial activity by adding 10 µL of DMSO and 90 µL of MH II cation adjusted broth into another 3 wells (3 replicates). Next, 50 µL of Mueller Hinton II cation-adjusted broth were added into each well, starting from the second row until the eighth row. Two-fold serial dilution was performed by taking 50 µL out from the first row into the wells of second row. The dilution was performed just until the wells of seventh row. Then, the last 50 µL from the wells of seventh row was discarded, resulting in each well containing 50 µL volume and the wells of the eighth row being the extract-free control (not containing plant extract suspension). Lastly, 50 µL of 106 CFU/mL microorganism inoculum was added into each well and mixed properly. For A. niger mould, the same procedure was followed but using YPD broth.
As a result, the plant extract suspension with 40,000 µg/mL was diluted from an initial concentration of 2000 µg/mL to a final concentration of 31.25 µg/mL, while the plant extract suspension with 20,000 µg/mL was diluted from an initial concentration of 1000 µg/mL to a final concentration of 15.63 µg/mL. Three replicates were made for each microbe/extract test. The microtiter plate was then covered and left for overnight incubation at 37 °C for the bacteria and yeast, and incubation for 2 days at 28 °C for Aspergillus niger, with 200 rpm. The shaking was needed to help the extract remains in suspension over the incubation period. The lowest concentration of the extract that will result in a complete inhibition of visible growth in the broth when compared to the extract free control will be the MIC.

2.6.2. Determination of MLC

Each MH II cation-adjusted agar plate was divided into 8 segments and labeled based on the respective concentration: 2000, 1000, 500, 250, 125, 62.5, 31.25, and 0 µg/mL for 40,000 µg/mL extract suspension or 1000, 500, 250, 125, 62.5, 31.25, 15.63, and 0 µg/mL for 20,000 µg/mL extract suspension. Twenty µL of sample was pipetted aseptically from each well and plated onto MH II cation-adjusted agar on its respective concentration section. The plates were allowed to air-dry, and the plates were then inverted and incubated at 37 °C for 18–24 h. MLC was evaluated as the lowest extract concentration at which no growth was observed on the plates. For A. niger the same procedure was used except the agar medium which was replaced by YPD and the incubation temperature was 28 °C.

2.7. Statistical Analysis of Data

Although the experiments were repeated three times for each plant extract against each microorganism, the average and standard deviation are not appropriate for MIC and MLC concentrations. The active concentrations of the extracts are exact amounts against each microorganism, and thus cannot be averaged. Instead, the median values were determined using GraphPad Prism software.

3. Results and Discussion

Although aromatic and medicinal plants have been used from ancient times as natural remedies and are considered as alternatives to complement the synthetic medications, in-depth scientific investigations must be conducted to study the antimicrobial properties of plant extracts. Thus, in this study, microbial susceptibility tests were conducted with 18 extracts produced from nine New Zealand endemic shrubs using liquid broth micro-dilution and plating techniques.

3.1. MIC and MLC of Antimicrobial Plant Extracts

Table 2 shows the MIC and MLC results for all the plant extracts tested. The results of G. ligustrifolium and M. ramiflorus are not in Table 2, as no antimicrobial activity was detected against the five microorganisms tested, so MLCs were not determined. K. ericoides (methanol extract) was the most antimicrobial, presenting the lowest MIC of 62.5 μg/mL against both B. cereus and C. albicans and 125 μg/mL against S. aureus. This extract showed a MLC of 250 μg/mL against both S. aureus and B. cereus. The ethyl acetate extract of the same plant was less antimicrobial, with a MIC of 125 μg/mL against both S. aureus and B. cereus, 250 μg/mL against C. albicans, and the MLC > 2000 μg/mL against B. cereus. The antimicrobial properties of K. ericoides against S. aureus are in agreement with a previous study [21]. Bloor (1995) also detected antimicrobial activity of K. ericoides aqueous methanolic extract against S. aureus and C. albicans [12]. As opposed to K. ericoides, the ethyl acetate P. colorata was much more active than the methanol extract, showing a MIC of 62.5 μg/mL against S. aureus compared with 1000 μg/mL for methanolic extract. A MIC of 125 μg/mL was shown for the methanol extract against B. cereus and C. albicans, as opposed to 500 μg/mL for the ethyl acetate extract of the same plant. With respect to C. albicans, ethyl acetate of P. colorata presented a MLC of 250, which was half of the MLC shown by the methanol extract. Previous results have also demonstrated good antimicrobial properties of P. colorata against C. albicans [23].
With respect to W. racemosa, methanol extract showed antimicrobial activity against S. aureus and B. cereus with the MIC of 250 μg/mL respectively and C. albicans with the MIC of 125 μg/mL. In addition, W. racemosa (methanol) also presented the MLC of 2000 μg/mL and 250 μg/mL against S. aureus and B. cereus, respectively. The ethyl acetate extract of W. racemosa displayed the MIC of 250 μg/mL against both S. aureus and B. cereus and 2000 μg/mL against C. albicans. W. racemosa (ethyl acetate) also had the MLC value of 2000 μg/mL against both S. aureus and C. albicans. Aqueous methanol extracts of W. racemosa were antimicrobial against Pseudomonas aeruginosa.
In general, P. tenax (ethyl acetate) was more antimicrobial than P. tenax (methanol) because the former inhibited or/and killed microorganisms at lower concentrations. P. tenax (ethyl acetate) indicated an activity against S. aureus with the MIC of 500 μg/mL and MLC of 2000 μg/mL, B. cereus with the MIC of 500 μg/mL, and E. coli with both MIC and MLC of 2000 μg/mL. MIC of methanol extract of P. tenax against S. aureus, B. cereus, and C. albicans was 1000 μg/mL, 2000 μg/mL, and 2000 μg/mL respectively.
The ethyl acetate extract of S. digitata revealed activity against S. aureus, B. cereus, and C. albicans with a MIC of 1000 μg/mL. S. digitata (EA) also showed the MLC of 1000 μg/mL against S. aureus and 2000 μg/mL against C. albicans. The methanol extract of S. digitata presented MICs of 2000 μg/mL, 500 μg/mL, and 2000 μg/mL against S. aureus, B. cereus, and C. albicans, respectively.
The methanol extract of P. kumeraho was antimicrobial against S. aureus, B. cereus, and C. albicans with the MIC of 1000 μg/mL, 500 μg/mL, and 1000 μg/mL respectively. The ethyl acetate extract did not exhibit any antimicrobial activity the five microorganisms tested.
The data indicated that methanol extract of H. stricta showed activity against B. cereus with a MIC of 2000 μg/mL. No activity was detected against the other four microorganisms tested.
A screening study carried out with methanol extracts from New Zealand endemic plants also showed antibiotic activity of the same plants we tested [24]: P. colorata exhibited activity against E. coli, S. aureus, and C. albicans; W. racemosa showed activity against E. coli and S. aureus; and Phormium tenax extracts against S. aureus.

3.2. Nature of Antimicrobial Effect

To determine the nature of antimicrobial effect of plant extracts, the ratio MLC/MIC was used. This ratio was calculated only for the antimicrobial plant extracts presenting MIC and MLC values. If the ratio was lower than 4, the extract was classified as microbicidal, which means it has a lethal effect. If the ratio was greater than 4, the extract was classified as microbiostatic, which means it inhibits growth, but is not lethal [25,26]. Table 3 shows the results. The following plant extracts are microbicidal as they presented a MLC/MIC ratio ≤ 2: K. ericoides methanol and ethyl acetate extracts against S. aureus; P. colorata methanol and ethyl acetate extracts are fungicidal against C. albicans; W. racemosa methanol extract is bactericidal against B. cereus and the ethyl acetate extract is fungicidal against C. albicans; P. tenax ethyl acetate extract is bactericidal against E. coli; S. digitata ethyl acetate extract is microbicidal against S. aureus and C. albicans.
The ethyl acetate extract of K. ericoides presented a MLC/MIC ratio of 4 against B. cereus. A similar result was obtained with the ethyl acetate extract of P. tenax against S. aureus. Lastly, both extracts of W. racemosa were only bacteriostatic against S. aureus as MLC/MIC = 8.

3.3. Microbial Susceptibility of Different Microorganisms

The mould A. niger was not susceptible to any of the extracts tested. Escherichia coli was also very resistant. It is commonly known that Gram-negative bacteria such E. coli are less susceptible to antimicrobials than Gram-positive bacteria such as S. aureus and B. cereus [27]. It is not known precisely why the Gram-negative E. coli was less susceptible to the plant extracts, but it may be perhaps due to the presence of an outer membrane, which endows the bacterial surface with strong hydrophilicity and acts as a strong permeability barrier, which restricts the diffusion of hydrophobic compounds through its lipopolysaccharide covering [28,29].

4. Conclusions

The results demonstrated that 12 out of the 18 produced plant extracts exhibited antimicrobial activity against at least one of the five microorganisms tested. In term of plant species, K. ericoides, P. colorata, and W. racemosa were the most antimicrobial plant extracts, followed by P. tenax, S. digitata, and P. kumeraho, and lastly H. stricta, G. ligustrifolium, and M. ramiflorus did not exhibit antimicrobial properties against the five microorganisms tested. The lowest MIC obtained was 62.5 µg/mL by K. ericoides methanol extract against both B. cereus and C. albicans, as well as by P. colorata (ethyl acetate) against S. aureus. The effects of the extracts on microorganisms were mostly microbicidal. The mould (fungus) Aspergillus niger was not susceptible to anyx of the extracts produced and the E. coli was only inhibited and killed by the ethyl acetate extract from P. tenax with both MIC and MLC of 2000 µg/mL. The less resistant microorganisms were S. aureus, followed by B. cereus and C. albicans.
It is essential to conduct further studies focusing on those plants which have been used traditionally by Māori as potential sources of novel antimicrobial compounds. The results of this study can help to accommodate the emerging demand for natural, safe, and effective antimicrobial products with potential applications for human health. The possibility of using plant materials as a source of natural products with potential antimicrobial properties is a very current issue. More detailed experiments should be carried out with the active extracts, namely cytotoxicity assessment and a chemical identification (e.g., HPLC) to identify the chemical composition of the extracts.

Author Contributions

Investigation, S.S. (Syahidi Safian) and H.M.; writing—original draft preparation, S.S. (Syahidi Safian); supervision and writing—review and editing, S.S. (Simon Swift) and F.V.M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the New Zealand Ministry of Business, Innovation and Employment “The Biocide ToolBox for New Zealand Manufacturing Exporters” (UOAX0812).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We acknowledge Janesha Perera for a great support at the Department of Molecular Medicine and Pathology, University of Auckland. The authors also acknowledge Fred Allen (Kiwi Plants Ltd., New Zealand) for identification and supply of plant material.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Struelens, M.J. The epidemiology of antimicrobial resistance in hospital acquired infections: Problems and possible solutions. BMJ 1998, 317, 652–654. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Friedrich, A.W. Control of hospital acquired infections and antimicrobial resistance in Europe: The way to go. Wien Med. Wochenschr. 2019, 169 (Suppl. S1), 25–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. World Health Organization. Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-resistant Bacterial Infections, Including Tuberculosis; WHO/EMP/IAU/2017.12; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
  4. de Sousa Andrade, L.M.; de Oliveira, A.B.M.; Leal, A.L.A.B.; de Alcântara Oliveira, F.A.; Portela, A.L.; de Sousa Lima Neto, J.; de Siqueira-Júnior, J.P.; Kaatz, G.W.; da Rocha, C.Q.; Barreto, H.M. Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda. Microb. Pathog. 2020, 140, 103935. [Google Scholar] [CrossRef] [PubMed]
  5. Harada, K.; Niina, A.; Nakai, Y.; Kataoka, Y.; Takahashi, T. Prevalence of antimicrobial resistance in relation to virulence genes and phylogenetic origins among urogenital Escherichia coli isolates from dogs and cats in Japan. Am. J. Vet. Res. 2012, 73, 409–417. [Google Scholar] [CrossRef]
  6. Solomon, F.B.; Wadilo, F.W.; Arota, A.A.; Abraham, Y.L. Antibiotic resistant airborne bacteria and their multidrug resistance pattern at University teaching referral Hospital in South Ethiopia. Ann. Clin. Microbiol. Antimicrob. 2017, 16, 1–7. [Google Scholar] [CrossRef]
  7. Żbikowska, B.; Franiczek, R.; Sowa, A.; Połukord, G.; Krzyzanowska, B.; Sroka, Z. Antimicrobial and Antiradical Activity of Extracts Obtained from Leaves of Five Species of the Genus Bergenia: Identification of Antimicrobial Compounds. Microb. Drug Resist. 2017, 23, 771–780. [Google Scholar] [CrossRef]
  8. Li, G.; Ma, X.; Deng, L.; Zhao, X.; Wei, Y.; Gao, Z.; Jia, J.; Xu, J.; Sun, C. Fresh garlic extract enhances the antimicrobial activities of antibiotics on resistant strains in vitro. Jundishapur J. Microbiol. 2015, 8, 1–6. [Google Scholar] [CrossRef] [Green Version]
  9. Bezerra, C.F.; Camilo, C.J.; Silva, M.K.N.; Freitas, T.S.; Ribeiro-Filho, J.; Coutinho, H.D.M. Vanillin selectively modulates the action of antibiotics against resistant bacteria. Microb. Pathog. 2017, 113, 265–268. [Google Scholar] [CrossRef]
  10. Williams, L.R.; Stockley, J.K.; Yan, W.; Home, V.N. Essential oils with high antimicrobial activity for therapeutic use. Int. J. Aromather. 1998, 8, 30–40. [Google Scholar] [CrossRef]
  11. Cowan, M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564–582. [Google Scholar] [CrossRef] [Green Version]
  12. Bloor, S.J. A survey of extracts of New Zealand indigenous plants for selected biological activities. N. Z. J. Bot. 1995, 33, 523–540. [Google Scholar] [CrossRef]
  13. Lis-Balchin, M.; Deans, S.; Hart, S. Bioactivity of New Zealand medicinal plant essential oils. Acta Hortic. 1996, 426, 13–30. [Google Scholar] [CrossRef]
  14. Majid, H.; Silva, F.V.M. Inhibition of enzymes important for Alzheimer’s disease by antioxidant extracts prepared from 15 New Zealand medicinal trees and bushes. J. R. Soc. N. Z. 2020, 50, 538–551. [Google Scholar] [CrossRef]
  15. Majid, H.; Silva, F.V.M. Improvement of butyrylcholinesterase enzyme inhibition and medicinal properties of extracts of Aristotelia serrata leaves by ultrasound extraction. Food Bioprod. Process. 2020, 124, 445–454. [Google Scholar] [CrossRef]
  16. Majid, H.; Silva, F.V.M. Optimisation of ultrasound assisted extraction of antiacetylcholinesterase and antioxidant compounds from manuka (Leptospermum scoparium) for use as a phytomedicine against Alzheimer’s disease. N. Z. J. For. Sci. 2020, 50, 12. [Google Scholar] [CrossRef]
  17. Majid, H.; Silva, F.V.M. Kanuka bush leaves for Alzheimer’s disease: Improved inhibition of β-secretase enzyme, antioxidant capacity and yield of extracts by ultrasound assisted extraction. Food Bioprod. Process. 2021, 128, 109–120. [Google Scholar] [CrossRef]
  18. Lawrence, S.A.; Burgess, E.J.; Pairama, C.; Black, A.; Patrick, W.M.; Mitchell, I.; Perry, N.B.; Gerth, M.L. Mātauranga-guided screening of New Zealand native plants reveals flavonoids from kānuka (Kunzea robusta) with anti-Phytophthora activity. J. R. Soc. N. Z. 2019, 49 (Suppl. S1), 137–154. [Google Scholar] [CrossRef] [Green Version]
  19. Brooker, S.G.; Cambie, R.C.; Cooper, R.C. New Zealand Medicinal Plant; revised edition; Reed Books: Auckland, New Zealand, 1987. [Google Scholar]
  20. Wan, M.; Bloor, S.; Foo, L.Y.; Loh, B.N. Screening of New Zealand plant extracts for inhibitory activity against HIV-1 protease. Phytother. Res. 1996, 10, 589–595. [Google Scholar] [CrossRef]
  21. Riley, M.; Enting, B. Māori Healing and Herbal: New Zealand Ethnobotanical Sourcebook; Viking Sevenseas N.Z.: Wellington, New Zealand, 1994. [Google Scholar]
  22. CLSI. M07 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard, 5th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2000; Volume 20. [Google Scholar]
  23. Tipa, R. Horopito the Māhori painkiller. Te Karaka 2006, 33, 50–51. [Google Scholar]
  24. Calder, V.L.; Cole, A.L.J.; Walker, J.R.L. Antibiotic compounds from New Zealand plants. III: A survey of some New Zealand plants for antibiotic substances. J. R. Soc. N. Z. 1986, 16, 69–181. [Google Scholar] [CrossRef]
  25. Pankey, G.A.; Sabath, L.D. Clinical Relevance of Bacteriostatic versus Bactericidal Activity in the Treatment of Gram-Positive Bacterial Infections. Clin. Infect. Dis. 2004, 39, 755–756. [Google Scholar]
  26. Sfeir, J.; Lefrançois, C.; Baudoux, D.; Derbré, S.; Licznar, P. In Vitro Antibacterial Activity of Essential Oils against Streptococcus pyogenes. Evid.-Based Complement. Altern. Med. 2013, 2013, 269161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Kalemba, D.; Kunicka, A. Antibacterial and Antifungal Properties of Essential Oils. Curr. Med. Chem. 2003, 10, 813–829. [Google Scholar] [CrossRef] [PubMed]
  28. Smith-Palmer, A.; Stewart, J.; Fyfe, L. Antimicrobial properties of plant essential oils and essences against five important food-borne pathogens. Lett. Appl. Microbiol. 1998, 26, 118–122. [Google Scholar] [CrossRef] [PubMed]
  29. Luqman, S.; Dwivedi, G.R.; Darokar, M.P.; Kalra, A.; Khanuja, S.P.S. Antimicrobial activity of Eucalyptus citriodora essential oil. Int. J. Essent. Oil Ther. 2008, 2, 69–75. [Google Scholar]
Table 1. Selection of New Zealand trees and shrubs investigated in this study: Scientific names, common Māori names, and ethnopharmacological uses *.
Table 1. Selection of New Zealand trees and shrubs investigated in this study: Scientific names, common Māori names, and ethnopharmacological uses *.
Scientific NameLocal NameType of PlantEthnopharmacological UsesScientist
Kunzea ericoideskānukatreeThe essential oils of several species of Myrtaceae have been found to have activity against Staphylococcus aureus; it was also mentioned in the discussion that they support antimicrobial results against S. aureus. Bark decoction relieved diarrhea and dysentery.
A weak infusion of the leaves was often given to a patient with a high temperature
Richard A, 1832
Pseudowintera coloratahoropito, pepper treesmall treeLeaves were used to cure skin disease, venereal diseases, diarrhea; decoction of the leaves was used for stomachache; leaves were chewed for toothache (dental analgesic); leaves rubbed on breast when weaning infants.
Sesquiterpenoid dialdehyde polygodial has strong antibiotic activity against Candida albicans (support the antimicrobial result against Candida)
Raoul E, 1844
Weinmannia
racemosa
kāmahitreeThe inner bark is laxative, and the bark infused in boiling water was a tonic medicineLinnaeus C. von
filius, 1782
Phormium tenaxharakeke, flaxevergreen perennial plantThe blanched base of the leaf or root was beaten to pulp, heated, or roasted, and applied hot to bring forward abscesses or tumors; leaves and roots have beneficial effects for cutaneous diseases such as ringworm, or venereal diseases.Forster JR and
Forster G, 1776
Schefflera digitatapatete,
umbrella tree, seven finger
treeThe sap was used on scrofulous sores and ringworm; the leaves contain farcarindiol, an acetylenic alcohol which shows remarkable specific activity against common dermatophyte fungi such as those causing ringworm.Forster JR and
Forster G, 1776
Pomaderris
kumeraho
kumarahoushrubLiquid from boiled leaves is a well-known relief for all chest complaints, bronchitis, and pulmonary tuberculosis; ointment applied for skin cancer; beneficial effect on kidneysCunningham A, 1839
Hebe strictakoromikoherbLeaves infusion is a powerful astringent for dysentery and other complaints; the leaves were chewed as a remedy for diarrhea; decoction taken for ulcers and venereal diseases.
Top shoots and young leaves (green or dried) boiled or eaten raw were a remedy for kidney and bladder troubles.
Jussieu AL de, 1789
Geniostoma ligustrifoliumhangehangeshrubThe sap was applied to skin diseases of children.Cunningham A, 1838
Melicytus
ramiflorus
māhoesmall treeThe leaves were boiled, and the liquid was used to bathe parts affected by rheumatism. The boiled leaves were bandaged on surfaces affected with scabies and a plaster of steamed leaves was placed over a stomach wound.Forster JR and
Forster G, 1776
* Information extracted from: Māori Plant Use, https://maoriplantuse.landcareresearch.co.nz (accessed on 16 May 2022); Brooker et al., 1987 [19]; Riley and Enting, 1994 [21].
Table 2. Minimum inhibitory concentration (MIC) and minimum lethal concentration (MLC) of methanol and ethyl acetate extracts of New Zealand medicinal plants *.
Table 2. Minimum inhibitory concentration (MIC) and minimum lethal concentration (MLC) of methanol and ethyl acetate extracts of New Zealand medicinal plants *.
Plant SpeciesExtractConcentration in µg/mLMicroorganisms
Staphylococcus aureusBacillus cereusCandida albicansEscherichia coliAspergillus niger
Kunzea ericoidesMethanolMIC12562.562.5>2000>2000
MLC250 a250>2000>2000>2000
Ethyl acetateMIC125125250>2000>2000
MLC250>2000>2000 a>2000>2000
Pseudowintera colorataMethanolMIC1000500500>1000>1000
MLC>1000 a>1000500>1000>1000
Ethyl acetateMIC62.5125125>1000>1000
MLC>1000 c>1000250 a>1000>1000
Weinmannia racemosaMethanolMIC250250125>2000>2000
MLC2000 b250>2000 a>2000>2000
Ethyl acetateMIC2502502000>2000>2000
MLC2000 a>2000 b2000>2000>2000
Phormium tenaxMethanolMIC100020002000>2000>2000
MLC>2000 a>2000>2000>2000>2000
Ethyl acetateMIC500500>20002000>2000
MLC2000 a>2000 a>20002000>2000
Schefflera digitataMethanolMIC20005002000>2000>2000
MLC>2000>2000>2000>2000>2000
Ethyl acetateMIC100010001000>2000>2000
MLC1000 a>20002000 a>2000>2000
Pomaderris kumerahoMethanolMIC10005001000>1000>1000
MLC>1000>1000>1000>1000>1000
Ethyl acetateMIC>1000>1000>1000>1000>1000
MLC>1000>1000>1000>1000>1000
Hebe strictaMethanolMIC>20002000>2000>2000>2000
MLC>2000>2000>2000>2000>2000
Ethyl acetateMICndndndndnd
MLCndndndndnd
* Pseudowintera colorata, Pomaderris kumeraho, and Melicytus ramiflorus extracts were not soluble at 2000 µg/mL, so the maximum concentration tested was 1000 µg/mL; no antimicrobial activity was detected for the methanol and ethyl acetate extracts of Geniostoma ligustrifolium (>2000 µg/mL), and Melicytus ramiflorus (>1000 µg/mL) at the highest concentration tested, and the results are not presented in the table; nd = not determined due to its high value of MIC in all methanol extracts; a Presented partial lethality at one concentration lower; b Presented partial lethality at two concentrations lower; c Presented partial lethality at three concentrations lower.
Table 3. MLC/MIC ratio for antimicrobial plant extracts against susceptible microorganisms *.
Table 3. MLC/MIC ratio for antimicrobial plant extracts against susceptible microorganisms *.
Plant Common NamePlant Botanical NameExtraction
Solvent
Susceptible
Microorganism
MLC/MIC
kānukaKunzea ericoidesMethanolStaphylococcus aureus2
Bacillus cereus4
Ethyl acetateS. aureus2
horopitoPseudowintera colorataMethanolCandida albicans1
Ethyl acetate2
kāmahiWeinmannia racemosaMethanolB. cereus1
S. aureus8
Ethyl acetateC. albicans1
S. aureus8
harakekePhormium tenaxEthyl acetateEscherichia coli1
S. aureus4
pateteSchefflera digitataEthyl acetateS. aureus1
C. albicans2
* MLC—minimum lethal concentration, MIC—minimum inhibitory concentration.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Safian, S.; Majid, H.; Swift, S.; Silva, F.V.M. Antimicrobial Properties against Human Pathogens of Medicinal Plants from New Zealand. Appl. Microbiol. 2022, 2, 357-366. https://doi.org/10.3390/applmicrobiol2020027

AMA Style

Safian S, Majid H, Swift S, Silva FVM. Antimicrobial Properties against Human Pathogens of Medicinal Plants from New Zealand. Applied Microbiology. 2022; 2(2):357-366. https://doi.org/10.3390/applmicrobiol2020027

Chicago/Turabian Style

Safian, Syahidi, Hafiz Majid, Simon Swift, and Filipa V. M. Silva. 2022. "Antimicrobial Properties against Human Pathogens of Medicinal Plants from New Zealand" Applied Microbiology 2, no. 2: 357-366. https://doi.org/10.3390/applmicrobiol2020027

Article Metrics

Back to TopTop